X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (799) 799
Publication (55) 55
Book Review (10) 10
Book Chapter (9) 9
Conference Proceeding (4) 4
Dissertation (2) 2
Book / eBook (1) 1
Paper (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (398) 398
activating-factor acetylhydrolase (315) 315
atherosclerosis (250) 250
activating-factor-acetylhydrolase (224) 224
index medicus (216) 216
male (198) 198
low-density-lipoprotein (191) 191
female (183) 183
animals (173) 173
biochemistry & molecular biology (173) 173
c-reactive protein (158) 158
inflammation (156) 156
platelet-activating factor acetylhydrolase (151) 151
coronary-heart-disease (141) 141
middle aged (140) 140
peripheral vascular disease (114) 114
phospholipase a (113) 113
risk factors (99) 99
adult (95) 95
1-alkyl-2-acetylglycerophosphocholine esterase (94) 94
middle-aged men (94) 94
aged (90) 90
cardiac & cardiovascular systems (90) 90
cardiovascular-disease (89) 89
1-alkyl-2-acetylglycerophosphocholine esterase - blood (82) 82
coronary-artery-disease (77) 77
heart-disease (74) 74
risk (73) 73
lipids (71) 71
1-alkyl-2-acetylglycerophosphocholine esterase - metabolism (70) 70
pharmacology & pharmacy (70) 70
lipoprotein-associated phospholipase a (66) 66
cholesterol (65) 65
mice (65) 65
artery-disease (62) 62
plasma (62) 62
platelet-activating factor (61) 61
myocardial-infarction (59) 59
oxidative stress (59) 59
cell biology (56) 56
biomarkers - blood (55) 55
lipoprotein-associated phospholipase a2 (51) 51
lp-pla (50) 50
cardiovascular disease (49) 49
high-density-lipoprotein (48) 48
lipoproteins (47) 47
phospholipases (47) 47
endocrinology & metabolism (45) 45
expression (44) 44
macrophages (44) 44
oxidation-reduction (44) 44
risk-factors (44) 44
medicine, research & experimental (43) 43
enzymes (42) 42
lipoprotein (42) 42
apolipoprotein-a-i (41) 41
human-plasma (40) 40
metabolic syndrome (40) 40
platelet-activating-factor (40) 40
research (40) 40
ldl (39) 39
coronary heart disease (38) 38
phospholipases a - metabolism (38) 38
platelet activating factor acetylhydrolase (38) 38
case-control studies (37) 37
low density lipoproteins (37) 37
lysophosphatidylcholine (37) 37
hdl (36) 36
lipoproteins, ldl - metabolism (36) 36
medicine, general & internal (36) 36
paraoxonase (36) 36
disease (35) 35
paf-acetylhydrolase (35) 35
phospholipases a2 (35) 35
endothelial-cells (34) 34
hematology (34) 34
medical laboratory technology (34) 34
oxidized phospholipids (34) 34
1-alkyl-2-acetylglycerophosphocholine esterase - genetics (33) 33
ischemic-stroke (33) 33
lipoproteins, hdl - metabolism (33) 33
oxidative modification (33) 33
physiological aspects (33) 33
cardiovascular (32) 32
lipoproteins, ldl - blood (32) 32
analysis (31) 31
darapladib (31) 31
lipid-peroxidation (31) 31
oxidation (31) 31
oxidized ldl (31) 31
cardiovascular diseases (30) 30
immunology (28) 28
paf-ah (27) 27
phospholipases a - blood (27) 27
cholesterol, ldl - blood (26) 26
diabetes (26) 26
follow-up (26) 26
human plasma (26) 26
biomarkers (25) 25
biophysics (25) 25
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (786) 786
Japanese (8) 8
Russian (4) 4
Chinese (2) 2
French (2) 2
Korean (2) 2
Spanish (2) 2
German (1) 1
Polish (1) 1
Slovak (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids, ISSN 1388-1981, 11/2006, Volume 1761, Issue 11, pp. 1246 - 1259
The superfamily of phospholipase A (PLA ) enzymes currently consists of 15 Groups and many subgroups and includes five distinct types of enzymes, namely the... 
Platelet activating factor acetylhydrolase | Prostaglandin | Arachidonic acid | Lipid mediator | Phospholipase A | Eicosanoid
Journal Article
Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists, ISSN 1530-891X, 04/2017, Volume 23, Issue Suppl 2, pp. 1 - 87
Journal Article
JOURNAL OF LIPID RESEARCH, ISSN 0022-2275, 04/2009, Volume 50, pp. S237 - S242
Tremendous advances in understanding the structure and function of the superfamily of phospholipase A(2) (PLA(2)) enzymes has occurred in the twenty-first... 
arachidonic acid | GROUP-V | EXCHANGE MASS-SPECTROMETRY | ACTIVATING-FACTOR ACETYLHYDROLASE | BIOCHEMISTRY & MOLECULAR BIOLOGY | C2 DOMAIN | RECOMBINANT EXPRESSION | phospholipids | EXPRESS GROUP | REDUCED FERTILITY | P388D MACROPHAGES | LIPOPROTEIN | ENZYMES | lipid signaling
Journal Article
Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids, ISSN 1388-1981, 10/2000, Volume 1488, Issue 1-2, pp. 1 - 19
The phospholipase A (PLA ) superfamily consists of a broad range of enzymes defined by their ability to catalyze the hydrolysis of the middle (sn-2) ester bond... 
Calcium-independent phospholipase A | Platelet activating factor acetylhydrolase | Secreted phospholipase A | Arachidonic acid | Phospholipase B | Cytosolic phospholipase A
Journal Article
LANCET, ISSN 0140-6736, 05/2010, Volume 375, Issue 9725, pp. 1536 - 1544
Journal Article
Journal of Medicinal Chemistry, ISSN 0022-2623, 12/2017, Volume 60, Issue 24, pp. 10231 - 10244
Lipoprotein-associated phospholipase A2 (Lp-PLA2) is a promising therapeutic target for atherosclerosis, Alzheimer's disease, and diabetic macular edema. Here... 
HEPATOCYTES | CHEMISTRY, MEDICINAL | EVENTS | ACID | ACTIVATING-FACTOR ACETYLHYDROLASE | ZINC-DEPENDENT INHIBITORS | SUPERFAMILY | A LP-PLA | DARAPLADIB | BINDING | AMIDES
Journal Article
JAMA, ISSN 0098-7484, 09/2014, Volume 312, Issue 10, pp. 1006 - 1015
Journal Article
by White, Harvey D and Held, Claes and Stewart, Ralph and Tarka, Elizabeth and Brown, Rebekkah and Davies, Richard Y and Budaj, Anzej and Harrington, Robert A and Steg, P. Gabriel and Ardissino, Diego and Armstrong, Paul W and Avezum, Alvaro and Aylward, Philip E and Bryce, Alfonso and Chen, Hong and Chen, Ming-Fong and Corbalan, Ramon and Dalby, Anthony J and Danchin, Nicolas and de Winter, Robbert J and Denchev, Stefan and Diaz, Rafael and Elisaf, Moses and Flather, Marcus D and Goudev, Assen R and Granger, Christopher B and Grinfeld, Liliana and Hochman, Judith S and Husted, Steen and Kim, Hyo-Soo and Koenig, Wolfgang and Linhart, Ales and Lonn, Eva and López-Sendón, José and Manolis, Athanasios J and Mohler, Emile R and Nicolau, José C and Pais, Prem and Parkhomenko, Alexander and Pedersen, Terje R and Pella, Daniel and Ramos-Corrales, Marco A and Ruda, Mikhail and Sereg, Mátyás and Siddique, Saulat and Sinnaeve, Peter and Smith, Peter and Sritara, Piyamitr and Swart, Henk P and Sy, Rody G and Teramoto, Tamio and Tse, Hung-Fat and Watson, David and Weaver, W. Douglas and Weiss, Robert and Viigimaa, Margus and Vinereanu, gos and Zhu, Junren and Cannon, Christopher P and Wallentin, Lars and Steg, Ph Gabriel and Bucan, Olga and Elfström, Charlotta and Hegg, Lisa and Jarosz, Marie and Krug-Gourley, Sue and Rudman, Jerry and Collins, Rory and Anderson, Jeffrey and DeMets, David and Ganz, Peter and Sandercock, Peter and Weber, Michael and Fisher, Marian and Buhr, Kevin and Diegel, Scott and Schultz, Melissa and Mahaffey, Kenneth W and Alexander, John H and Al-Khatib, Sana and Baron, Tomasz and Bergström, Olle and Bushnell, Cheryl and Christersson, Christina and Eggers, Kai and Fredlund, Bengt-Olov and Hagström, Emil and Hijazi, Ziad and Örndahl, Lovisa Holm and James, Stefan K and Jernberg, Tomas and Johnston, Nina and Lopez, Renato D and Mehta, Rajena H and Newby, Kristin L and Nordmark, Örjan and Oldgren, Jonas and Roe, Matthew T and Saldéen, Katarina and Stenborg, Anna and ... and The STABILITY Investigators and STABILITY Investigators and Medicinska fakulteten and Medicinska och farmaceutiska vetenskapsområdet and Kardiologi and Medicinska och farmaceutiska vetenskapsområdet, centrumbildningar mm and Uppsala universitet and Institutionen för medicinska vetenskaper and Uppsala kliniska forskningscentrum (UCR)
The New England Journal of Medicine, ISSN 0028-4793, 05/2014, Volume 370, Issue 18, pp. 1702 - 1711
Darapladib, an oral inhibitor of lipoprotein-associated phospholipase A2, was compared with placebo in 15,828 patients with stable coronary heart disease.... 
TRIAL | LIPOPROTEIN | MEDICINE, GENERAL & INTERNAL | THERAPY | ACTIVATING-FACTOR ACETYLHYDROLASE | OXIDIZED LDL | RISK | PHOSPHOLIPASE A | ATHEROSCLEROTIC PLAQUE | INHIBITOR | CLINICAL-OUTCOMES | Stroke - prevention & control | Double-Blind Method | Follow-Up Studies | Oximes - adverse effects | Phospholipase A2 Inhibitors - administration & dosage | Humans | Middle Aged | Kaplan-Meier Estimate | Oximes - administration & dosage | Male | Coronary Artery Disease - drug therapy | Coronary Disease - mortality | Phospholipase A2 Inhibitors - adverse effects | Benzaldehydes - adverse effects | Benzaldehydes - administration & dosage | Coronary Artery Disease - complications | Treatment Failure | Coronary Disease - drug therapy | Female | Aged | Myocardial Infarction - prevention & control | Prevention | Care and treatment | Ischemia | Dosage and administration | Research | Coronary heart disease | Cardiovascular agents | Myocardial infarction | Cerebral infarction | Phospholipase A2 | Clinical trials | Myocardial ischemia | Cardiovascular disease | Angina | Preventive medicine | Coronary artery disease | Phospholipase | Arteriosclerosis | Death | Plasma levels | Drug therapy | Heart diseases | Plaques | Malalties cardiovasculars | Infart de miocardi | Malalties coronàries | Assaigs clínics de medicaments | Cardiovascular diseases | Drug testing | Coronary diseases | Clinical Medicine | Medical and Health Sciences | Klinisk medicin | Medicin och hälsovetenskap
Journal Article